Pacira BioSciences to Present at the 2021 RBC Capital Markets Global Healthcare Conference

Rhea-AI Summary

Pacira BioSciences, Inc. (NASDAQ: PCRX) will present at the 2021 RBC Capital Markets Global Healthcare Conference on May 18, 2021, at 10:20 AM ET. The virtual event will feature live audio accessible via the company’s website. A replay will be available for two weeks post-event.

Pacira is a leader in non-opioid pain management solutions, known for its long-acting local analgesic, EXPAREL®, which was launched in April 2012. In 2019, the company expanded its portfolio by acquiring the iovera°® system, enhancing its commitment to innovative pain management.

News Market Reaction – PCRX

+2.08%

+2.08% Session move

In the trading session that priced this news, PCRX gained 2.08%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PARSIPPANY, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2021 RBC Capital Markets Global Healthcare Conference at 10:20 AM ET on Tuesday, May 18, 2021. Live audio of the virtual event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira         

Pacira BioSciences, Inc. (Nasdaq: PCRX) is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera°® system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

FAQ

When will Pacira BioSciences present at the RBC Capital Markets Global Healthcare Conference?

Pacira BioSciences will present on May 18, 2021, at 10:20 AM ET.

How can I access the live audio of Pacira's presentation?

The live audio can be accessed on the Events page of Pacira's website.

Will there be a replay of Pacira's presentation at the conference?

Yes, a replay of the webcast will be available for two weeks after the event.

What is EXPAREL® and when was it launched?

EXPAREL®, a long-acting local analgesic, was commercially launched in the United States in April 2012.

What is the iovera°® system and when did Pacira acquire it?

The iovera°® system is a handheld cryoanalgesia device acquired by Pacira in April 2019.